Search Results for

Showing 1 - 10 of 14 results
  1. Spotlight on members: Spark

    Spotlight on members From hospital funding to FDA approval Spark Therapeutics develops gene therapy for inherited retinal blindness After over two decades of research and development in gene therapy, Katherine A. High, MD, co-founder, president and chief scientific officer of Spark Therapeutics, is breathing a big sigh of relief this fall. On Oct. 12, the Food and Drug Administration unanimously voted to approve voretigene neparvovec, Spark Therapeutics' gene therapy treatment for inherited b

  2. Housing and registration

    Registration and housing Registration Rates shown in U.S. dollars   Advance rate Onsite rate   Through July 6, 2018      After July 6, 2018 Regular attendee $495 $515 Student attendee*      $295 $315  *Students are undergraduate and graduate students, post-graduate fellows, medical students, optometry students and residents. Registration includes: 2.5 days of programming Coffee breaks, two lunches, one opening reception Champalimaud facility tour option (sign-up o

  3. Program

    Program Conference program The final conference program will include podium sessions, with opening and closing keynote lectures, a tour of the Champalimaud Centre for the Unknown, poster sessions and multiple opportunities for attendees to network. Speakers are international experts in oncogenesis and oncology, from the Champalimaud Centre for the Unknown and other ophthalmic centers around the globe.  Program schedule overview Wednesday, July 18 – afternoon registration hours (Attendees may

  4. Abstracts

    Abstracts Call for abstracts Abstract submission is open through Friday, March 23, 2018. The Ocular Oncogenesis and Oncology organizers seeks high-quality abstracts describing original, unpublished research results that contain a clear statement of hypothesis, an explanation of methods, a report of data that unequivocally test the hypothesis, and a brief discussion of their implications. Abstract reference tools Abstract Submission Policies and Procedures Abstract Submission FAQs Abstrac

  5. Statement for the Use of Animals in Ophthalmic and Vision Research

    Statement for the Use of Animals in Ophthalmic and Vision Research Introduction Guidelines for the design of experiments Guidelines for the conduct of experiments Factors that relate specifically to the conduct of vision and ophthalmology experiments Investigators outside the United States Animal use guidelines Alternatives to animal research Animal use resources Organizations that promote proper and ethical use of laboratory animals Introduction Research in vision and ophthalmology i

  6. Registration

    NIH Updates for Human Subjects Research Administration

  7. Meeting policies

    Meeting policies ARVO Anti-harassment Policy The Association for Research in Vision and Ophthalmology (ARVO) has zero tolerance for discrimination and all forms of harassment, including but not limited to sexual harassment. This zero-tolerance policy means that no form of discriminatory or harassing conduct by or toward any ARVO member, exhibitor, presenter, attendee or staff member will be tolerated. This includes, but it not limited to: harassment toward another individual on the basis of

  8. About

    Online event: May 22, 2018

  9. Meeting justification

    Why should you attend ARVO 2018? Justification Suggestions Attending the 2018 ARVO Annual Meeting will be the most cost-effective professional development and learning experience choice you make all year. The volume of new research, idea-sharing and networking that takes place over five days is unmatched in any other setting. Tips for getting support to attend the ARVO Annual Meeting Explain in specific terms what you will gain or obtain by attending, and how that will benefit your wor

Website Status

We are currently experiencing technical difficulties with our website. The login is not working. We are working on resolving this problem as quickly as possible and apologize for any inconvenience this may cause. If you need assistance please email